Mouse avatars could speed up AML treatment discovery

NCT ID NCT06782971

Recruiting now Knowledge-focused Sponsor: Clinical Hub for Interventional Research (CHOIR) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to develop a faster way to test new drug combinations for acute myeloid leukemia (AML). Researchers will take blood and bone marrow samples from 25 adults with AML and grow their cancer cells in special mice. They will then test how well standard treatments work in these mice and compare the results to the patients' actual responses. The goal is to create a platform that can quickly identify promising treatments for individual patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AML (ACUTE MYELOID LEUKEMIA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AML (ACUTE MYELOID LEUKEMIA)

Contacts and locations

Locations

Canberra Health Services
RECRUITING

Canberra, Australian Capital Territory, 2605, Australia
Prince of Wales Hospital
RECRUITING

Sydney, New South Wales, 2031, Australia
Royal North Shore Hospital
NOT_YET_RECRUITING

Sydney, New South Wales, 2065, Australia
Westmead Hospital
RECRUITING

Westmead, New South Wales, 2145, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.